Skip to content

Effect of isomaltose complex gynecological gel in patients with polycystic ovary syndrome undergoing in vitro fertilization and embryo transfer

Clinical study on the efficacy and safety of isomaltose-oligosaccharide combined gynecological gel in freeze-thaw embryo transfer in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095301
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

study group:Vaginal gel was used before embryo transfer
control group:No

Sponsors

Sichuan Provincial Women’s and Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with PCOS undergoing FET in Sichuan Provincial Women’s and Children’s Hospital. Age range: 20-40 years old.

Exclusion criteria

Exclusion criteria: 1) Allergy to the gel and any of its ingredients; 2) Uterine submucous and intermuscular myoma, uterine adenomyosis, uterine adhesions, uterine malformations and other factors affecting embryo implantation; 3) Chronic diseases of cardiovascular system, respiratory system and digestive system, immune diseases such as systemic lupus erythematosus, and metabolic diseases; 4) Have participated in other drug clinical trials or device clinical trials within 3 months before treatment, and have used experimental drugs or used experimental devices; 5) Other medical conditions identified by the investigator that may affect the judgment of this study.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;

Secondary

MeasureTime frame
Vaginal microbiota situation;

Countries

China

Contacts

Public ContactGong Yan

Sichuan Provincial Women’s and Children’s Hospital

gongyan_496181657@qq.com+86 152 0839 3996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026